Ciloxan Ophthalmic Ointment/Solution

Ciloxan, containing the active ingredient Ciprofloxacin, is a well-known antibiotic medication used primarily for treating eye and ear infections. The brand was originally developed by Alcon, a company with deep roots in the ophthalmic industry that was founded in Texas, USA, in 1945.

Over the years, the ownership of Alcon shifted significantly. It was acquired by the Swiss food and beverage giant Nestlé in 1977, and later fully acquired by Novartis between 2008 and 2011. However, in 2019, Novartis spun Alcon off into a standalone, independent public company. Today, Alcon is a global leader in eye care, headquartered in Geneva, Switzerland, and Fort Worth, Texas.

Manufacturing of Ciloxan takes place in various specialized pharmaceutical facilities around the world, including locations in the United States, Belgium, and France. The specific manufacturing site often depends on the regional market it is intended for and the specific formulation (drops or ointment).